Callio Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $187,000,000
Company Info
- Company Description
- Callio Therapeutics is focused on advancing a multi-payload antibody-drug conjugate platform through clinical proof-of-concept.
- Market
- Pharmaceuticals
- Location
- United States